These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34119877)

  • 21. Prediction of fetal growth restriction using estimated fetal weight vs a combined screening model in the third trimester.
    Miranda J; Rodriguez-Lopez M; Triunfo S; Sairanen M; Kouru H; Parra-Saavedra M; Crovetto F; Figueras F; Crispi F; Gratacós E
    Ultrasound Obstet Gynecol; 2017 Nov; 50(5):603-611. PubMed ID: 28004439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Placental glucose transporter 1 and 3 gene expression in Monochorionic twin pregnancies with selective fetal growth restriction.
    Chang YL; Chao AS; Chang SD; Cheng PJ
    BMC Pregnancy Childbirth; 2021 Mar; 21(1):260. PubMed ID: 33773574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population.
    Kienast C; Moya W; Rodriguez O; Jijón A; Geipel A
    J Matern Fetal Neonatal Med; 2016; 29(4):537-43. PubMed ID: 25708492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Second Trimester Placental Growth Factor Levels and Placental Histopathology in Low-Risk Nulliparous Pregnancies.
    Audette MC; McLaughlin K; Kingdom JC
    J Obstet Gynaecol Can; 2021 Oct; 43(10):1145-1152.e1. PubMed ID: 33621677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced growth velocity from the mid-trimester is associated with placental insufficiency in fetuses born at a normal birthweight.
    Kennedy LM; Tong S; Robinson AJ; Hiscock RJ; Hui L; Dane KM; Middleton AL; Walker SP; MacDonald TM
    BMC Med; 2020 Dec; 18(1):395. PubMed ID: 33357243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction?
    Benton SJ; Hu Y; Xie F; Kupfer K; Lee SW; Magee LA; von Dadelszen P
    Am J Obstet Gynecol; 2012 Feb; 206(2):163.e1-7. PubMed ID: 22055338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Correlates of Placental Pathologic Features in Early-Onset Fetal Growth Restriction.
    Spinillo A; Meroni A; Melito C; Scatigno AL; Tzialla C; Fiandrino G; Cesari S; Gardella B
    Fetal Diagn Ther; 2022; 49(5-6):215-224. PubMed ID: 35158358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Individual risk assessment for prenatal counseling in early-onset growth-restricted and small-for-gestational-age fetuses.
    Mendoza M; Hurtado I; Bonacina E; Garcia-Manau P; Serrano B; Tur H; Rodo C; Maiz N; Carreras E
    Acta Obstet Gynecol Scand; 2021 Mar; 100(3):504-512. PubMed ID: 33098097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinctive patterns of placental lesions in pre-eclampsia vs small-for-gestational age and their association with fetoplacental Doppler.
    Paules C; Youssef L; Rovira C; Crovetto F; Nadal A; Peguero A; Figueras F; Eixarch E; Crispi F; Miranda J; Gratacós E
    Ultrasound Obstet Gynecol; 2019 Nov; 54(5):609-616. PubMed ID: 31115105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic accuracy of fetal growth charts for placenta-related fetal growth restriction.
    Melamed N; Hiersch L; Aviram A; Mei-Dan E; Keating S; Kingdom JC
    Placenta; 2021 Feb; 105():70-77. PubMed ID: 33556716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association between placenta-associated circulating biomarkers and composite adverse delivery outcome of a likely placental cause in healthy post-date pregnancies.
    Bowe S; Mitlid-Mork B; Georgieva A; Gran JM; Redman CWG; Staff AC; Sugulle M
    Acta Obstet Gynecol Scand; 2021 Oct; 100(10):1893-1901. PubMed ID: 34212381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians.
    Vayssière C; Sentilhes L; Ego A; Bernard C; Cambourieu D; Flamant C; Gascoin G; Gaudineau A; Grangé G; Houfflin-Debarge V; Langer B; Malan V; Marcorelles P; Nizard J; Perrotin F; Salomon L; Senat MV; Serry A; Tessier V; Truffert P; Tsatsaris V; Arnaud C; Carbonne B
    Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():10-8. PubMed ID: 26207980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of Kryptor and Elecsys® immunoassay sFlt-1/PlGF ratio on early diagnosis of preeclampsia and fetal growth restriction: A case-control study.
    Simón E; Herraiz I; Villalaín C; Gómez-Arriaga PI; Quezada MS; López-Jiménez EA; Galindo A
    Pregnancy Hypertens; 2020 Apr; 20():44-49. PubMed ID: 32172169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal change of sFlt-1/PlGF ratio in singleton pregnancy with early-onset fetal growth restriction.
    Herraiz I; Quezada MS; Rodriguez-Calvo J; Gómez-Montes E; Villalaín C; Galindo A
    Ultrasound Obstet Gynecol; 2018 Nov; 52(5):631-638. PubMed ID: 28876491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the PLGF in the management of pregnancies complicated with fetal microsomia.
    Souka AP; Chatziioannou MI; Pegkou A; Antsaklis P; Daskalakis G
    Arch Gynecol Obstet; 2024 Apr; 309(4):1369-1376. PubMed ID: 36977917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ten-year experience of protocol-based management of small-for-gestational-age fetuses: perinatal outcome in late-pregnancy cases diagnosed after 32 weeks.
    Meler E; Mazarico E; Eixarch E; Gonzalez A; Peguero A; Martinez J; Boada D; Vellvé K; Gomez-Roig MD; Gratacós E; Figueras F
    Ultrasound Obstet Gynecol; 2021 Jan; 57(1):62-69. PubMed ID: 33159370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertensive Disorders of Pregnancy and Fetal Growth Restriction: Clinical Characteristics and Placental Lesions and Possible Preventive Nutritional Targets.
    Di Martino DD; Avagliano L; Ferrazzi E; Fusè F; Sterpi V; Parasiliti M; Stampalija T; Zullino S; Farina A; Bulfamante GP; Di Maso M; D'Ambrosi F
    Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-regulation of placental neuropilin-1 in fetal growth restriction.
    Maulik D; De A; Ragolia L; Evans J; Grigoryev D; Lankachandra K; Mundy D; Muscat J; Gerkovich MM; Ye SQ
    Am J Obstet Gynecol; 2016 Feb; 214(2):279.e1-279.e9. PubMed ID: 26409917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defining early vs late fetal growth restriction by placental pathology.
    Aviram A; Sherman C; Kingdom J; Zaltz A; Barrett J; Melamed N
    Acta Obstet Gynecol Scand; 2019 Mar; 98(3):365-373. PubMed ID: 30372519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PlGF in a clinical setting of pregnancies at risk of preeclampsia and/or intrauterine growth restriction.
    Cetin I; Mazzocco MI; Giardini V; Cardellicchio M; Calabrese S; Algeri P; Martinelli A; Todyrenchuk L; Vergani P
    J Matern Fetal Neonatal Med; 2017 Jan; 30(2):144-149. PubMed ID: 27028483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.